These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26970658)

  • 1. Effect of background parenchymal enhancement on breast cancer detection with magnetic resonance imaging.
    Telegrafo M; Rella L; Stabile Ianora AA; Angelelli G; Moschetta M
    Diagn Interv Imaging; 2016 Mar; 97(3):315-20. PubMed ID: 26970658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices.
    Ray KM; Kerlikowske K; Lobach IV; Hofmann MB; Greenwood HI; Arasu VA; Hylton NM; Joe BN
    Radiology; 2018 Mar; 286(3):822-829. PubMed ID: 29072981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Background Parenchymal Enhancement on Screening Magnetic Resonance Imaging in Women Who Received Chest Radiotherapy for Childhood Hodgkin's Lymphoma.
    Zeng L; Lo G; Moshonov H; Liang J; Hodgson D; Crystal P
    Acad Radiol; 2016 Feb; 23(2):168-75. PubMed ID: 26546383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast MRI background parenchymal enhancement (BPE) correlates with the risk of breast cancer.
    Telegrafo M; Rella L; Stabile Ianora AA; Angelelli G; Moschetta M
    Magn Reson Imaging; 2016 Feb; 34(2):173-6. PubMed ID: 26597834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation.
    Giess CS; Yeh ED; Raza S; Birdwell RL
    Radiographics; 2014; 34(1):234-47. PubMed ID: 24428293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.
    King V; Goldfarb SB; Brooks JD; Sung JS; Nulsen BF; Jozefara JE; Pike MC; Dickler MN; Morris EA
    Radiology; 2012 Sep; 264(3):670-8. PubMed ID: 22771878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated surgeries in invasive lobular breast cancer with preoperative MRI: Role of additional carcinoma in situ and background parenchymal enhancement.
    Preibsch H; Richter V; Bahrs SD; Hattermann V; Wietek BM; Bier G; Kloth C; Blumenstock G; Hahn M; Staebler A; Nikolaou K; Wiesinger B
    Eur J Radiol; 2017 May; 90():181-187. PubMed ID: 28583631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Performance of and Breast Tissue Changes at Early Breast MR Imaging Surveillance in Women after Breast Conservation Therapy.
    Kim EJ; Kang BJ; Kim SH; Youn IK; Baek JE; Lee HS
    Radiology; 2017 Sep; 284(3):656-666. PubMed ID: 28419815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Background Parenchymal Enhancement on Pre-Operative Breast Magnetic Resonance Imaging: How It Affects Interpretation and the Role of Second-Look Ultrasound in Patient Management.
    Kim SY; Lee HS; Kim EK; Kim MJ; Moon HJ; Yoon JH
    Ultrasound Med Biol; 2016 Dec; 42(12):2766-2774. PubMed ID: 27658753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.
    Sogani J; Morris EA; Kaplan JB; D'Alessio D; Goldman D; Moskowitz CS; Jochelson MS
    Radiology; 2017 Jan; 282(1):63-73. PubMed ID: 27379544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of background parenchymal enhancement in breast contrast-enhanced ultrasound with Sonazoid
    Haga M; Hirai T; Nakai T; Kobayashi T; Nakamura T; Marugami A; Ito T; Takewa M; Marugami N; Kichikawa K
    J Med Ultrason (2001); 2020 Oct; 47(4):591-601. PubMed ID: 32989596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Background parenchymal enhancement in breast magnetic resonance imaging: A review of current evidences and future trends.
    Rella R; Bufi E; Belli P; Contegiacomo A; Giuliani M; Rosignuolo M; Rinaldi P; Manfredi R
    Diagn Interv Imaging; 2018 Dec; 99(12):815-826. PubMed ID: 30249463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.
    Arasu VA; Miglioretti DL; Sprague BL; Alsheik NH; Buist DSM; Henderson LM; Herschorn SD; Lee JM; Onega T; Rauscher GH; Wernli KJ; Lehman CD; Kerlikowske K
    J Clin Oncol; 2019 Apr; 37(12):954-963. PubMed ID: 30625040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of background parenchymal enhancement on breast MRI: a systematic review.
    Bignotti B; Signori A; Valdora F; Rossi F; Calabrese M; Durando M; Mariscotto G; Tagliafico A
    Br J Radiol; 2017 Feb; 90(1070):20160542. PubMed ID: 27925480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated With Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
    Karimi Z; Phillips J; Slanetz P; Lotfi P; Dialani V; Karimova J; Mehta T
    AJR Am J Roentgenol; 2021 Feb; 216(2):340-348. PubMed ID: 32755162
    [No Abstract]   [Full Text] [Related]  

  • 16. The Association of Background Parenchymal Enhancement at Breast MRI with Breast Cancer: A Systematic Review and Meta-Analysis.
    Thompson CM; Mallawaarachchi I; Dwivedi DK; Ayyappan AP; Shokar NK; Lakshmanaswamy R; Dwivedi AK
    Radiology; 2019 Sep; 292(3):552-561. PubMed ID: 31237494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Background parenchymal enhancement over exam time in patients with and without breast cancer.
    Melsaether A; Pujara AC; Elias K; Pysarenko K; Gudi A; Dodelzon K; Babb JS; Gao Y; Moy L
    J Magn Reson Imaging; 2017 Jan; 45(1):74-83. PubMed ID: 27285396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of background parenchymal enhancement in whole breast on MRI: Influence of menstrual cycle and comparison with a qualitative analysis.
    Jung Y; Jeong SK; Kang DK; Moon Y; Kim TH
    Eur J Radiol; 2018 Jun; 103():84-89. PubMed ID: 29803391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Assessment of Breast Parenchymal Uptake on 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI.
    Leithner D; Baltzer PA; Magometschnigg HF; Wengert GJ; Karanikas G; Helbich TH; Weber M; Wadsak W; Pinker K
    J Nucl Med; 2016 Oct; 57(10):1518-1522. PubMed ID: 27230924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI Texture Analysis of Background Parenchymal Enhancement of the Breast.
    Amano Y; Woo J; Amano M; Yanagisawa F; Yamamoto H; Tani M
    Biomed Res Int; 2017; 2017():4845909. PubMed ID: 28812015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.